Cargando…
Validation of a risk prediction model for Barrett’s esophagus in an Australian population
BACKGROUND: Esophageal adenocarcinoma is a disease that has a high mortality rate, the only known precursor being Barrett’s esophagus (BE). While screening for BE is not cost-effective at the population level, targeted screening might be beneficial. We have developed a risk prediction model to ident...
Autores principales: | Ireland, Colin J, Gordon, Andrea L, Thompson, Sarah K, Watson, David I, Whiteman, David C, Reed, Richard L, Esterman, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878665/ https://www.ncbi.nlm.nih.gov/pubmed/29628770 http://dx.doi.org/10.2147/CEG.S158627 |
Ejemplares similares
-
Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia
por: Grin, Andrea, et al.
Publicado: (2014) -
The treatment of Barrett’s esophagus
por: Hoara, Petre, et al.
Publicado: (2009) -
TissueCypher Barrett’s esophagus assay impacts clinical decisions in the management of patients with Barrett’s esophagus
por: Diehl, David L., et al.
Publicado: (2021) -
Barrett's esophagus : columnar lined esophagus
Publicado: (2003) -
Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus
por: Gharahkhani, Puya, et al.
Publicado: (2016)